Endometrial Carcinoma MSI (MSK, Clin Cancer Res 2022)

Summary

Endometrial Carcinoma MSI (MSK, Clin Cancer Res 2022) is a study catalogued by cBioPortal DataHub under the cancer-type code ucec. EvidenceHelix groups it with gynecologic studies.

Study description

Clinical and genetic features of microsatellite instability-high endometrial cancers harboring germline or somatic mutations in MMR genes or MLH1 promoter hypermethylation.

Text as published in the source's study metadata.

Citation & PubMed

Linked PubMed records: PMID 35849120

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

ucec_ccr_msk_2022

Short name

UCEC MSI MSK 2022

Source cancer-type code

ucec

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

• PubMed record 35849120 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Endometrial Cancer (MSK, 2018)

  MSK-IMPACT sequencing of 197 advanced-staged endometrial cancer tumor samples with matched normals, from 189 patients treated at MSK.

  GynecologicMSK studiesSource code ucecPubMed 1

• Endometrial Cancer (MSK, Cancer Discovery 2023)

  Targeted sequencing of 1882 endometrial cancers and their matched normals via MSK-IMPACT.

  GynecologicMSK studiesSource code ucecPubMed 1

• Endometrial Carcinoma (MSK, Molecular Oncology 2024)

  Targeted sequencing of 69 ERBB2-mutant endometrial carcinoma tumors and their matched normal pairs via MSK-IMPACT.

  GynecologicMSK studiesSource code ucecPubMed 1

• Endometrial Carcinoma cfDNA (MSK, Clin Cancer Res 2022)

  High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer.

  GynecologicMSK studiesSource code ucecPubMed 1

• Endometrial Carcinoma (CPTAC, Cell 2020)

  Proteogenomic Characterization of Endometrial Carcinoma. Generated by CPTAC.

  GynecologicOther published and consortium studiesSource code ucecPubMed 1

• Uterine Corpus Endometrial Carcinoma (TCGA, Firehose Legacy)

  TCGA Uterine Corpus Endometrial Carcinoma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/UCEC/20160128/). Previously known as TCGA Provisional.

  GynecologicTCGA Firehose LegacySource code ucec

• Uterine Corpus Endometrial Carcinoma (TCGA, Nature 2013)

  Whole exome sequencing of 373 endometrial carcinoma tumors with matched normals. TCGA Uterine Corpus Endometrial Carcinoma project; raw data at the NCI (https://tcga-data.nci.nih.gov/docs/publications/ucec_2013/).

  GynecologicTCGA (other releases)Source code ucecPubMed 1

• Uterine Corpus Endometrial Carcinoma (TCGA, PanCancer Atlas)

  Uterine Corpus Endometrial Carcinoma TCGA PanCancer data. The original data is here (https://gdc.cancer.gov/about-data/publications/pancanatlas). The publications are here (https://www.cell.com/pb-assets/consortium/pa…

  GynecologicTCGA PanCancer AtlasSource code ucecPubMed 12

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.